ID

36841

Description

MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT02399189

Link

https://clinicaltrials.gov/show/NCT02399189

Keywords

Versions (1)
  1. 6/14/19 6/14/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 14, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Primary Central Nervous System Lymphoma NCT02399189

English

Eligibility Primary Central Nervous System Lymphoma NCT02399189

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
primary central nervous system diffuse large b-cell lymphoma histologically confirmed by brain biopsy
Description

Diffuse large B-cell lymphoma of central nervous system Primary Brain biopsy

Data type

boolean

Alias
UMLS CUI [1,1]
C2026186
UMLS CUI [1,2]
C0205225
UMLS CUI [1,3]
C0740294
ecog 0-2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
absence of systemic disease as evaluated by chest-abdomen-pelvis ct scan
Description

Systemic disease Absent CT of chest, abdomen and pelvis

Data type

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C1688605
leucocytes>3.500/mm3, platelets>130.000/mm3, bilirubin < 2 mg, transaminases < 2.5 n), creatinine < 150 μm/l, creatinine clearance > 50 ml/min/1.73m2
Description

White Blood Cell Count procedure | Platelet Count measurement | Serum total bilirubin measurement | Transaminase Assay | Creatinine measurement, serum | Creatinine clearance measurement

Data type

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0032181
UMLS CUI [3]
C1278039
UMLS CUI [4]
C0919834
UMLS CUI [5]
C0201976
UMLS CUI [6]
C0373595
age 18-65 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
negative hiv test
Description

HIV test negative

Data type

boolean

Alias
UMLS CUI [1]
C0854048
signature of informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy for primary central nervous system lymphoma
Description

Prior Chemotherapy Primary central nervous system lymphoma

Data type

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0280803
presence of another cancer (excepting basal cell carcinoma of the skin and cervical carcinoma in situ )
Description

Cancer Other | Exception Basal cell carcinoma | Exception Carcinoma in situ of uterine cervix

Data type

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
systemic lymphoma (outside the cns)
Description

Lymphoma Systemic | Central Nervous System Excluded

Data type

boolean

Alias
UMLS CUI [1,1]
C0024299
UMLS CUI [1,2]
C0205373
UMLS CUI [2,1]
C3714787
UMLS CUI [2,2]
C0332196
isolated ocular lymphoma
Description

Ocular lymphoma Isolated

Data type

boolean

Alias
UMLS CUI [1,1]
C0730306
UMLS CUI [1,2]
C0205409
immunosuppressed patients (hiv , use of immunosuppressors)
Description

Immunosuppressed patients | HIV Infection | Use of Immunosuppressive Agents

Data type

boolean

Alias
UMLS CUI [1]
C0085393
UMLS CUI [2]
C0019693
UMLS CUI [3,1]
C1524063
UMLS CUI [3,2]
C0021081
other uncontrolled or progressive disease compromising shot-term survival
Description

Disease Uncontrolled | Progressive Disease | Short-term Survival At risk

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C1335499
UMLS CUI [3,1]
C0038952
UMLS CUI [3,2]
C0443303
UMLS CUI [3,3]
C1444641
severe renal or hepatic disease
Description

Kidney Disease Severe | Liver disease Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0022658
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0023895
UMLS CUI [2,2]
C0205082
patients not legally covered by the french social security
Description

Social Security Coverage Lacking

Data type

boolean

Alias
UMLS CUI [1,1]
C0037435
UMLS CUI [1,2]
C1551362
UMLS CUI [1,3]
C0332268
inability to swallow the medication
Description

Lacking Able to swallow Oral medication

Data type

boolean

Alias
UMLS CUI [1,1]
C0332268
UMLS CUI [1,2]
C2712086
UMLS CUI [1,3]
C0175795
Back to the top of the page

Similar models

Eligibility Primary Central Nervous System Lymphoma NCT02399189

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Diffuse large B-cell lymphoma of central nervous system Primary Brain biopsy
Item
primary central nervous system diffuse large b-cell lymphoma histologically confirmed by brain biopsy
boolean
C2026186 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C0740294 (UMLS CUI [1,3])
ECOG performance status
Item
ecog 0-2
boolean
C1520224 (UMLS CUI [1])
Systemic disease Absent CT of chest, abdomen and pelvis
Item
absence of systemic disease as evaluated by chest-abdomen-pelvis ct scan
boolean
C0442893 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1688605 (UMLS CUI [1,3])
White Blood Cell Count procedure | Platelet Count measurement | Serum total bilirubin measurement | Transaminase Assay | Creatinine measurement, serum | Creatinine clearance measurement
Item
leucocytes>3.500/mm3, platelets>130.000/mm3, bilirubin < 2 mg, transaminases < 2.5 n), creatinine < 150 μm/l, creatinine clearance > 50 ml/min/1.73m2
boolean
C0023508 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
C0919834 (UMLS CUI [4])
C0201976 (UMLS CUI [5])
C0373595 (UMLS CUI [6])
Age
Item
age 18-65 years
boolean
C0001779 (UMLS CUI [1])
HIV test negative
Item
negative hiv test
boolean
C0854048 (UMLS CUI [1])
Informed Consent
Item
signature of informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Chemotherapy Primary central nervous system lymphoma
Item
prior chemotherapy for primary central nervous system lymphoma
boolean
C1514457 (UMLS CUI [1,1])
C0280803 (UMLS CUI [1,2])
Cancer Other | Exception Basal cell carcinoma | Exception Carcinoma in situ of uterine cervix
Item
presence of another cancer (excepting basal cell carcinoma of the skin and cervical carcinoma in situ )
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
Lymphoma Systemic | Central Nervous System Excluded
Item
systemic lymphoma (outside the cns)
boolean
C0024299 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C3714787 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
Ocular lymphoma Isolated
Item
isolated ocular lymphoma
boolean
C0730306 (UMLS CUI [1,1])
C0205409 (UMLS CUI [1,2])
Immunosuppressed patients | HIV Infection | Use of Immunosuppressive Agents
Item
immunosuppressed patients (hiv , use of immunosuppressors)
boolean
C0085393 (UMLS CUI [1])
C0019693 (UMLS CUI [2])
C1524063 (UMLS CUI [3,1])
C0021081 (UMLS CUI [3,2])
Disease Uncontrolled | Progressive Disease | Short-term Survival At risk
Item
other uncontrolled or progressive disease compromising shot-term survival
boolean
C0012634 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C1335499 (UMLS CUI [2])
C0038952 (UMLS CUI [3,1])
C0443303 (UMLS CUI [3,2])
C1444641 (UMLS CUI [3,3])
Kidney Disease Severe | Liver disease Severe
Item
severe renal or hepatic disease
boolean
C0022658 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Social Security Coverage Lacking
Item
patients not legally covered by the french social security
boolean
C0037435 (UMLS CUI [1,1])
C1551362 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
Lacking Able to swallow Oral medication
Item
inability to swallow the medication
boolean
C0332268 (UMLS CUI [1,1])
C2712086 (UMLS CUI [1,2])
C0175795 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial